Insight Article Desktop Banner
Global Fixed Income Bulletin
February 29, 2020

It’s All About the Virus

Insight Video Mobile Banner
February 29, 2020

It’s All About the Virus

Global Fixed Income Bulletin

It’s All About the Virus

Share Icon

February 29, 2020


February marked a watershed in the evolution of the coronavirus (COVID-19) outbreak and its ramifications. Through February 19 (the day the S&P hit its all-time high), optimism reigned. The world thought this health crisis was likely to be contained to Asia, predominantly China, with a relatively small impact on the U.S. and European economies. It was a temporary supply shock, disrupting supply chains, but importantly, it would not materially affect 2020 cumulative economic performance, either in the U.S. or China. Lost output could be made up without lasting impact on demand. So much for wishful thinking! By the end of the month, the 10-year U.S. Treasury yield was at a record low, equities were down close to double digits and high yield had a negative return year to date.


The failure to contain the spread of the coronavirus to China (and Asia) changed the game. The world now faces an aggregate demand shock (above and beyond a short-term collapse in Chinese demand) on top of the original Asian supply shock. Economic growth will take a bigger hit (although there is nothing really evident in the data yet). The hit will last longer. It will be global. And, maybe worst of all, no one knows when it will end. The Brookings Institute has come up with SEVEN potential scenarios. There are probably a lot more than that! This uncertainty will weigh on economies and financial markets until there is evidence that infection rates are likely to have peaked. Recession is likely in countries already facing weak economic prognoses and weak policy frameworks. Other countries, probably the U.S., will escape recession but at the cost of a stagnating economy. Volatility will stay high; government bonds should continue to be well supported; risky assets should struggle (financial markets were not well positioned for the plethora of bad news delivered post February 19). Medium term, this crisis should pass and economies return to normal. When and how much pain is felt along the way will determine how low yields go and how wide credit spreads move. As long as the virus’s impact remains disruptive rather than destructive, we should be fine, eventually. Buckle your seat belts!

Display 1: Asset Performance Year-To-Date

Note: USD-based performance. Source: Bloomberg. Data as of February 29, 2020. The indexes are provided for illustrative purposes only and are not meant to depict the performance of a specific investment. Past performance is no guarantee of future results. See below for index definitions.

Display 2: Currency Monthly Changes Versus USD

Source: Bloomberg. Data as of February 29, 2020. Note: Positive change means appreciation of the currency against the USD.

Display 3: Major Monthly Changes in 10-Year Yields and Spreads

Source: Bloomberg, JP Morgan. Data as of Feb 29, 2020.


Fixed Income Outlook

February has been a match of two halves: Pre-February 19 the outlook was still optimistic, post February 19, goldilocks has been postponed, maybe indefinitely. Before the 19th, the outlook was a continuation of the steady recovery which characterized the end of 2019. Equities rallying and government bonds rallying, credit performing well in spite of some minor spread widening due to the tight levels at the end of 2019 and risks surrounding the coronavirus. By the end of February, markets had had their worst week since the 2008 financial crisis and the 10-Year Treasury Note hit historic lows, as the coronavirus continued to spread across the globe. By now it’s clear the coronavirus pandemic will have a meaningful impact on the global economy. While consensus had been that the worst impact would be felt in the first quarter and a recovery in the second quarter, this is now likely overly optimistic. We increasingly believe uncertainty is unlikely to be resolved until at least late in the second quarter.

Thus, thinking about the outlook for the next few months is tricky to say the least. The coronavirus creates a fluid situation for markets with no one certain about how long and far it will run. On the positive side, it appears to be receding in China, where it started, allowing the economy to start to recover; some other Asian economies – Japan, Singapore, and Taiwan – have been remarkably successful at containing the virus. On the negative side, infections outside of China, particularly in Europe, have been accelerating and are only just to pick up in the U.S. and many other countries. A public health failure in just one or two major economies could be severely disruptive to the entire global economy.

Fixed income markets have reacted to the increased risk sentiment with risk free duration rallying and credit spreads widening (investment grade, high yield and emerging markets). With government bond yields making new all-time lows in many advanced economies, it is not clear how much further they can fall, unless economies move into recession. Central banks have responded with emergency easing – rate cuts as well as measures to ease monetary conditions and keep liquidity flowing – but the market was quick to anticipate this response and significant rate cuts have been priced for every developed economy central bank.

Looking forward, the debate is whether the impact will merely be “disruptive” to the global economy, with a rebound in economic activity following the current slowdown, or “destructive,” with the timeline uncertain and longer term damage inflicted. Our base case is still for it to be disruptive with open questions over (1) the timeline to the peak in the infection rate, (2) the impact on consumer/business confidence and (3) the level where markets offer extreme value. The good news is that we are seeing both central banks and governments moving into action, with combined monetary and fiscal stimulus, but it remains to be seen if the response will be enough to calm markets.

While monetary accommodation is not a solution to a medical problem, and will have limited effect in cushioning the economy from a supply side shock, it can help prevent monetary conditions from tightening. The Fed’s surprise emergency rate cut (50 bps) in early March was extremely important in this regard. Moreover, we expect central banks and fiscal authorities to deliver on credit easing measures to support corporate/household cash flows and their access to credit.

Developed Markets

Monthly Review

In February, yields fell to historic levels across the globe as markets braced for the social and economic impact of the coronavirus, as the virus continued to rapidly spread outside of China. Other geopolitical risks around the globe took a backseat as the coronavirus was the main driver of market moves, particularly at the end of the month. The OECD slashed its global growth forecasts for 2020 from 2.9% to 2.4%. 10-year global yields across the developed markets dropped, including 36 basis points on the United States Treasury, 25 basis points in New Zealand, and 17 basis points in Germany. The VIX closed the month at 40%, which was close to a 5-year high, signaling increased concern among investors of the impacts the coronavirus will have on the global economy. U.S. breakevens fell, with the 10-year breakeven ending the month at 1.43.1 The reinversion of the Treasury yield curve and collapse of real yields was also indicative of uncertainty about the economy.


The global outlook is contingent on the coronavirus’ path and pace at which it spreads in the coming weeks. Expectations are that the virus spreads to the EU and U.S., posing serious disruptive risks to the regional and global economy, even if the Chinese economy is starting to normalize. If the situation continues to worsen, particularly in the U.S., the Fed is likely to deliver on additional rate cuts at its March meeting or soon after. The Fed could reset rates back at the lows seen after the global financial crisis. The Fed has promised to help stabilize financial markets, and is committed to being flexible regarding interest rate policy. If the spread of the virus slows, we believe there could be a sharp global rebound. The risk of a meaningful recession is unlikely if labor markets do not weaken.

Emerging Markets

Monthly Review

Emerging markets (EM) fixed income asset performance was negative in the month, as investors reduced risk due to the uncertainty surrounding the spread and economic impact of COVID-19. EM currencies weakened versus the U.S. dollar, while local bond returns were flat as bond yields failed to match the decline in Treasury yields. Inflows into the asset class ($4.4bn) continued for most of the month, primarily into hard currency strategies ($4.1bn), while local currency strategies gained $0.2bn. Many central banks cut rates or enacted other easing measures to combat the slowdown in economic activity.2


We remain cautious on EM debt in the near term, on the back of a still fluid situation regarding the Covid-19 virus. The transmission of the coronavirus shock through the global economy is likely to come from different sources: the demand-side (as declining consumer confidence weighs on private consumption), the financial sector (an equity sell-off implies a negative shock to wealth, and thus consumption, whereas wider spreads translate into tighter financial conditions and thus reduced corporate investment), and from the supply-side, as quarantines and other emergency measures disrupt global supply chains. In our view, we think the demand/financial channel is the most significant one, and as a result, monetary/fiscal policy accommodation may prove effective in mitigating the shock and providing some needed stabilization to financial assets. Markets have already priced in over 100 bps of Fed easing in the next year, and other Central Banks are likely to follow suit with their own monetary policy easing. In addition, some countries affected by the virus have also announced small fiscal stimuli (for example, Italy), which could be expanded depending on the severity of the shock.


Monthly Review

Unsurprisingly, the key driver of credit spreads in February was the uncertainty surrounding the coronavirus and its impact on economic activity and market/business confidence. Additional weak economic data (started before the virus), Q4 2019 corporate results that were ahead of lowered expectations and the start of U.S. election news were all discussed, but were not material market movers.


In February we continued to be conservative in our credit positioning, participating in a limited number of new issues while maintaining an unchanged risk exposure, long of credit but less long following sales in Q4 2019.

We see the coronavirus as a “fluid situation” for markets with new cases continuing to increase and more regions being impacted. Fixed income markets have reacted to the increased risk sentiment with risk-free duration rallying and credit spreads widening. Looking forward the debate is whether the impact will be “disruptive” or “destructive.”

Securitized Products

Monthly Review

As with the other sectors, coronavirus was the dominant story in February, with U.S. interest rates rallying sharply to new lows and equities selling off materially. In an ironic twist, the securitized markets had essentially an opposite reaction, where government guaranteed agency MBS was the worst performing asset class, while credit-oriented securitized assets performed well. While this sounds counter-intuitive, this market dynamic actually makes sense when one drills a little deeper. Credit-oriented securitized assets performed well during the month driven by the continued demand for yield, and also supported by continued strong fundamental market conditions. Agency MBS underperformed as lower rates increased prepayment concerns and limited how much agency MBS prices could rise.


We are generally more cautious in the securitized markets as we enter March, given the potential economic consequences of the virus outbreak. We continue to add to our government guaranteed agency MBS positions, and are slowly reducing some of our credit exposures. We remain positive on mortgage and securitized markets overall from a fundamental perspective, but we believe that liquidity and volatility conditions could deteriorate, and markets could cheapen in the coming weeks as a result. Agency MBS has cheapened meaningfully over the past two years and now look attractive on a risk-adjusted relative value basis, while securitized credit opportunities have widened less than their corporate equivalents in recent weeks.


1 Source: Bloomberg. Data as of February 29, 2020

2 Source: JP Morgan. Data as of February 29, 2020



Fixed-income securities are subject to the ability of an issuer to make timely principal and interest payments (credit risk), changes in interest rates (interest rate risk), the creditworthiness of the issuer and general market liquidity (market risk). In a rising interest-rate environment, bond prices may fall and may result in periods of volatility and increased portfolio redemptions. In a declining interest-rate environment, the portfolio may generate less income. Longer-term securities may be more sensitive to interest rate changes. Certain U.S. government securities purchased by the strategy, such as those issued by Fannie Mae and Freddie Mac, are not backed by the full faith and credit of the U.S. It is possible that these issuers will not have the funds to meet their payment obligations in the future. Public bank loans are subject to liquidity risk and the credit risks of lower-rated securities. High-yield securities (junk bonds) are lower-rated securities that may have a higher degree of credit and liquidity risk. Sovereign debt securities are subject to default risk. Mortgage- and asset-backed securities are sensitive to early prepayment risk and a higher risk of default, and may be hard to value and difficult to sell (liquidity risk). They are also subject to credit, market and interest rate risks. The currency market is highly volatile. Prices in these markets are influenced by, among other things, changing supply and demand for a particular currency; trade; fiscal, money and domestic or foreign exchange control programs and policies; and changes in domestic and foreign interest rates. Investments in foreign markets entail special risks such as currency, political, economic and market risks. The risks of investing in emerging market countries are greater than the risks generally associated with foreign investments. Derivative instruments may disproportionately increase losses and have a significant impact on performance. They also may be subject to counterparty, liquidity, valuation, correlation and market risks. Restricted and illiquid securities may be more difficult to sell and value than publicly traded securities (liquidity risk). Due to the possibility that prepayments will alter the cash flows on collateralized mortgage obligations (CMOs), it is not possible to determine in advance their final maturity date or average life. In addition, if the collateral securing the CMOs or any third-party guarantees are insufficient to make payments, the portfolio could sustain a loss.

The Global Fixed Income team follows a seamless process with a global outlook. They seek to identify and capture the potential value in situations where the market's implied forecasts are extreme.



The indexes shown in this report are not meant to depict the performance of any specific investment, and the indexes shown do not include any expenses, fees or sales charges, which would lower performance. The indexes shown are unmanaged and should not be considered an investment. It is not possible to invest directly in an index.

The Bloomberg Barclays Euro Aggregate Corporate Index (Bloomberg Barclays Euro IG Corporate) is an index designed to reflect the performance of the euro-denominated investment-grade corporate bond market.

The Bloomberg Barclays Global Aggregate Corporate Index is the corporate component of the Barclays Global Aggregate index, which provides a broad-based measure of the global investment-grade fixed income markets.

The Bloomberg Barclays U.S. Corporate Index (Bloomberg Barclays U.S. IG Corp) is a broad-based benchmark that measures the investment-grade, fixed-rate, taxable corporate bond market.

The Bloomberg Barclays U.S. Corporate High Yield Index measures the market of USD-denominated, non-investment grade, fixed-rate, taxable corporate bonds. Securities are classified as high yield if the middle rating of Moody’s, Fitch, and S&P is Ba1/BB+/BB+ or below. The index excludes emerging market debt.

The Bloomberg Barclays U.S. Mortgage Backed Securities (MBS) Index tracks agency mortgage-backed pass-through securities (both fixed-rate and hybrid ARM) guaranteed by Ginnie Mae (GNMA), Fannie Mae (FNMA) and Freddie Mac (FHLMC). The index is constructed by grouping individual TBA-deliverable MBS pools into aggregates or generics based on program, coupon and vintage. Introduced in 1985, the GNMA, FHLMC and FNMA fixed-rate indexes for 30- and 15-year securities were backdated to January 1976, May 1977 and November 1982, respectively. In April 2007, agency hybrid adjustable-rate mortgage (ARM) pass-through securities were added to the index.

Consumer Price Index (CPI) is a measure that examines the weighted average of prices of a basket of consumer goods and services, such as transportation, food and medical care.

Euro vs. USD—Euro total return versus U.S. dollar.

German 10YR bonds—Germany Benchmark 10-Year Datastream Government Index; Japan 10YR government bonds —Japan Benchmark 10-Year Datastream Government Index; and 10YR U.S. Treasury—U.S. Benchmark 10-Year Datastream Government Index.

The ICE BofAML European Currency High-Yield Constrained Index (ICE BofAML Euro HY constrained) is designed to track the performance of euro- and British pound sterling-denominated below investment-grade corporate debt publicly issued in the eurobond, sterling

The ICE BofAML U.S. Mortgage-Backed Securities (ICE BofAML U.S. Mortgage Master) Index tracks the performance of U.S. dollar-denominated, fixed-rate and hybrid residential mortgage pass-through securities publicly issued by U.S. agencies in the U.S. domestic market.

The ICE BofAML U.S. High Yield Master II Constrained Index (ICE BofAML U.S. High Yield) is a market value-weighted index of all domestic and Yankee high-yield bonds, including deferred-interest bonds and payment-in-kind securities. Its securities have maturities of one year or more and a credit rating lower than BBB-/Baa3, but are not in default.

The ISM Manufacturing Index is based on surveys of more than 300 manufacturing firms by the Institute of Supply Management. The ISM Manufacturing Index monitors employment, production inventories, new orders and supplier deliveries. A composite diffusion index is created that monitors conditions in national manufacturing based on the data from these surveys.

Italy 10-Year Government Bonds—Italy Benchmark 10-Year Datastream Government Index.

The JP Morgan CEMBI Broad Diversified Index is a global, liquid corporate emerging markets benchmark that tracks U.S.-denominated corporate bonds issued by emerging markets entities.

The JPMorgan Government Bond Index—Emerging markets (JPM local EM debt) tracks local currency bonds issued by emerging market governments. The index is positioned as the investable benchmark that includes only those countries that are accessible by most of the international investor base (excludes China and India as of September 2013).

The JPMorgan Government Bond Index Emerging Markets (JPM External EM Debt) tracks local currency bonds issued by emerging market governments. The index is positioned as the investable benchmark that includes only those countries that are accessible by most of the international investor base (excludes China and India as of September 2013).

The JP Morgan Emerging Markets Bond Index Global (EMBI Global) tracks total returns for traded external debt instruments in the emerging markets and is an expanded version of the EMBI+. As with the EMBI+, the EMBI Global includes U.S. dollar-denominated Brady bonds, loans and eurobonds with an outstanding face value of at least $500 million.

The JP Morgan GBI-EM Global Diversified Index is a market-capitalization weighted, liquid global benchmark for U.S.-dollar corporate emerging market bonds representing Asia, Latin America, Europe and the Middle East/Africa.

JPY vs. USD—Japanese yen total return versus U.S. dollar.

The National Association of Realtors Home Affordability Index compares the median income to the cost of the median home.

The Nikkei 225 Index (Japan Nikkei 225) is a price-weighted index of Japan’s top 225 blue-chip companies on the Tokyo Stock Exchange.

The MSCI AC Asia ex-Japan Index (MSCI Asia ex-Japan) captures large- and mid-cap representation across two of three developed markets countries (excluding Japan) and eight emerging markets countries in Asia.

MSCI Emerging Markets Index (MSCI emerging equities) captures large- and mid-cap representation across 23 emerging markets (EM) countries.

The MSCI World Index (MSCI developed equities) captures large and mid-cap representation across 23 developed market (DM) countries.

The S&P 500® Index (U.S. S&P 500) measures the performance of the large-cap segment of the U.S. equities market, covering approximately 75 percent of the U.S. equities market. The index includes 500 leading companies in leading industries of the U.S. economy.

The S&P/LSTA U.S. Leveraged Loan 100 Index (S&P/LSTA Leveraged Loan Index) is designed to reflect the performance of the largest facilities in the leveraged loan market.

The S&P GSCI Copper Index (Copper), a sub-index of the S&P GSCI, provides investors with a reliable and publicly available benchmark for investment performance in the copper commodity market.

The S&P GSCI Softs (GSCI soft commodities) Index is a sub-index of the S&P GSCI that measures the performance of only the soft commodities, weighted on a world production basis. In 2012, the S&P GSCI Softs Index included the following commodities: coffee, sugar, cocoa and cotton.

Spain 10-Year Government Bonds—Spain Benchmark 10-Year Datastream Government Index.

U.K. 10YR government bonds—U.K. Benchmark 10-Year Datastream Government Index. For the following Datastream government bond indexes, benchmark indexes are based on single bonds. The bond chosen for each series is the most representative bond available for the given maturity band at each point in time. Benchmarks are selected according to the accepted conventions within each market. Generally, the benchmark bond is the latest issue within the given maturity band; consideration is also given to yield, liquidity, issue size and coupon.

The U.S. Dollar Index (DXY) is an index of the value of the United States dollar relative to a basket of foreign currencies, often referred to as a basket of U.S. trade partners’ currencies.


This communication is only intended for and will only be distributed to persons resident in jurisdictions where such distribution or availability would not be contrary to local laws or regulations.

Ireland: Morgan Stanley Investment Management (Ireland) Limited. Registered Office: The Observatory, 7-11 Sir John Rogerson's, Quay, Dublin 2, Ireland. Registered in Ireland under company number 616662.  Regulated by the Central Bank of Ireland. United Kingdom: Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority. Registered in England. Registered No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA, authorised and regulated by the Financial Conduct Authority. Dubai: Morgan Stanley Investment Management Limited (Representative Office, Unit Precinct 3-7th Floor-Unit 701 and 702, Level 7, Gate Precinct Building 3, Dubai International Financial Centre, Dubai, 506501, United Arab Emirates. Telephone: +97 (0)14 709 7158). Germany: Morgan Stanley Investment Management Limited Niederlassung Deutschland, Grosse Gallusstrasses 18, 60312 Frankfurt am Main, Germany (Gattung: Zweigniederlassung (FDI) gem. § 53b KWG). Italy: Morgan Stanley Investment Management Limited, Milan Branch (Sede Secondaria di Milano) is a branch of Morgan Stanley Investment Management Limited, a company registered in the U.K., authorised and regulated by the Financial Conduct Authority (FCA), and whose registered office is at 25 Cabot Square, Canary Wharf, London, E14 4QA. Morgan Stanley Investment Management Limited Milan Branch (Sede Secondaria di Milano) with seat in Palazzo Serbelloni Corso Venezia, 16 20121 Milano, Italy, is registered in Italy with company number and VAT number 08829360968. The Netherlands: Morgan Stanley Investment Management, Rembrandt Tower, 11th Floor Amstelplein 1 1096HA, Netherlands. Telephone: 31 2-0462-1300. Morgan Stanley Investment Management is a branch office of Morgan Stanley Investment Management Limited. Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Switzerland: Morgan Stanley & Co. International plc, London, Zurich BranchI Authorised and regulated by the Eidgenössische Finanzmarktaufsicht (“FINMA”). Registered with the Register of Commerce Zurich CHE-115.415.770. Registered Office: Beethovenstrasse 33, 8002 Zurich, Switzerland, Telephone +41 (0) 44 588 1000. Facsimile Fax: +41(0)44 588 1074.

Japan: For professional investors, this document is circulated or distributed for informational purposes only. For those who are not professional investors, this document is provided in relation to Morgan Stanley Investment Management (Japan) Co., Ltd. (“MSIMJ”)’s business with respect to discretionary investment management agreements (“IMA”) and investment advisory agreements (“IAA”). This is not for the purpose of a recommendation or solicitation of transactions or offers any particular financial instruments. Under an IMA, with respect to management of assets of a client, the client prescribes basic management policies in advance and commissions MSIMJ to make all investment decisions based on an analysis of the value, etc. of the securities, and MSIMJ accepts such commission. The client shall delegate to MSIMJ the authorities necessary for making investment. MSIMJ exercises the delegated authorities based on investment decisions of MSIMJ, and the client shall not make individual instructions. All investment profits and losses belong to the clients; principal is not guaranteed. Please consider the investment objectives and nature of risks before investing. As an investment advisory fee for an IAA or an IMA, the amount of assets subject to the contract multiplied by a certain rate (the upper limit is 2.20 percent per annum (including tax)) shall be incurred in proportion to the contract period. For some strategies, a contingency fee may be incurred in addition to the fee mentioned above. Indirect charges also may be incurred, such as brokerage commissions for incorporated securities. Since these charges and expenses are different depending on a contract and other factors, MSIMJ cannot present the rates, upper limits, etc. in advance. All clients should read the Documents Provided Prior to the Conclusion of a Contract carefully before executing an agreement. This document is disseminated in Japan by MSIMJ, Registered No. 410 (Director of Kanto Local Finance Bureau (Financial Instruments Firms)), Membership: the Japan Securities Dealers Association,   The Investment Trusts Association, Japan, the Japan Investment Advisers Association and the Type II Financial Instruments Firms Association.


A separately managed account may not be suitable for all investors. Separate accounts managed according to the Strategy include a number of securities and will not necessarily track the performance of any index. Please consider the investment objectives, risks and fees of the Strategy carefully before investing. A minimum asset level is required. For important information about the investment manager, please refer to Form ADV Part 2.

Please consider the investment objectives, risks, charges and expenses of the funds carefully before investing. The prospectuses contain this and other information about the funds. To obtain a prospectus please download one at or call 1-800-548-7786. Please read the prospectus carefully before investing.

Morgan Stanley Distribution, Inc. serves as the distributor for Morgan Stanley Funds.


Hong Kong: This document has been issued by Morgan Stanley Asia Limited for use in Hong Kong and shall only be made available to “professional investors” as defined under the Securities and Futures Ordinance of Hong Kong (Cap 571). The contents of this document have not been reviewed nor approved by any regulatory authority including the Securities and Futures Commission in Hong Kong. Accordingly, save where an exemption is available under the relevant law, this document shall not be issued, circulated, distributed, directed at, or made available to, the public in Hong Kong. Singapore: This document should not be considered to be the subject of an invitation for subscription or purchase, whether directly or indirectly, to the public or any member of the public in Singapore other than (i) to an institutional investor under section 304 of the Securities and Futures Act, Chapter 289 of Singapore (“SFA”), (ii) to a “relevant person” (which includes an accredited investor) pursuant to section 305 of the SFA, and such distribution is in accordance with the conditions specified in section 305 of the SFA; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. This publication has not been reviewed by the Monetary Authority of Singapore. Australia: This publication is disseminated in Australia by Morgan Stanley Investment Management (Australia) Pty Limited ACN: 122040037, AFSL No. 314182, which accept responsibility for its contents. This publication, and any access to it, is intended only for “wholesale clients” within the meaning of the Australian Corporations Act.


EMEA: This communication has been issued by Morgan Stanley Investment Management Limited (“MSIM”). Authorised and regulated by the Financial Conduct Authority. Registered in England No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA.

There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market. Prior to investing, investors should carefully review the strategy’s / product’s relevant offering document. There are important differences in how the strategy is carried out in each of the investment vehicles.

A separately managed account may not be suitable for all investors.

Separate accounts managed according to the Strategy include a number of securities and will not necessarily track the performance of any index. Please consider the investment objectives, risks and fees of the Strategy carefully before investing.

The views and opinions are those of the author or the investment team as of the date of preparation of this material and are subject to change at any time due to market or economic conditions and may not necessarily come to pass. Furthermore, the views will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date of publication. The views expressed do not reflect the opinions of all investment teams at Morgan Stanley Investment Management (MSIM) or the views of the firm as a whole, and may not be reflected in all the strategies and products that the Firm offers.

Forecasts and/or estimates provided herein are subject to change and may not actually come to pass. Information regarding expected market returns and market outlooks is based on the research, analysis and opinions of the authors. These conclusions are speculative in nature, may not come to pass and are not intended to predict the future performance of any specific Morgan Stanley Investment Management product.

Certain information herein is based on data obtained from third party sources believed to be reliable. However, we have not verified this information, and we make no representations whatsoever as to its accuracy or completeness.

This communication is not a product of Morgan Stanley’s Research Department and should not be regarded as a research recommendation. The information contained herein has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This material is a general communication, which is not impartial and has been prepared solely for informational and educational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. All investments involve risks, including the possible loss of principal. The information herein has not been based on a consideration of any individual investor circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.

Any index referred to herein is the intellectual property (including registered trademarks) of the applicable licensor. Any product based on an index is in no way sponsored, endorsed, sold or promoted by the applicable licensor and it shall not have any liability with respect thereto.

MSIM has not authorised financial intermediaries to use and to distribute this document, unless such use and distribution is made in accordance with applicable law and regulation. Additionally, financial intermediaries are required to satisfy themselves that the information in this document is suitable for any person to whom they provide this document in view of that person’s circumstances and purpose. MSIM shall not be liable for, and accepts no liability for, the use or misuse of this document by any such financial intermediary.

This document may be translated into other languages. Where such a translation is made this English version remains definitive. If there are any discrepancies between the English version and any version of this document in another language, the English version shall prevail.

The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without MSIM’s express written consent.

Morgan Stanley Investment Management is the asset management division of Morgan Stanley.

All information contained herein is proprietary and is protected under copyright law.